Facebook LinkedIn Twitter RSS Feeds March 30, 2016 at 12:00 AM EDT Back Regeneron and Sanofi to Present Phase 3 Praluent® (alirocumab) Injection Clinical Trial Data at ACC.16 ACC.16 Final Media Advisory.pdf 270.1 KB